Of note, neither TCR conferred cytotoxic activity against HLA matched BxPC-3 tumor cells, a KRAS WT pancreatic adenocarcinoma cell line, validating the specificity of each TCR for the cognate G12V peptide. This evidence concerns the gene KRAS and pancreatic adenocarcinoma.